Company Focus – CME Group Acquisition of NEX
CME Group has announced that it has reached an agreement to acquire NEX Group plc, a London-based company offering technology and tools to support pre- and post-trade activities across a range of OTC products. The acquisition is valued at USD5.5b and has reminded competitors that CME Group is still a major force in the global exchange industry. The transaction may also be the spark that reignites M&A activity within the global exchange industry, as the sector has seen little activity in recent years.
Burton-Taylor has pulled together the details of the deal and drawn on its extensive knowledge of the industry to analyze how the acquisition will enhance CME’s suite of product offerings.
The analysis includes a profile of both CME and NEX businesses, listing of the important deal logistics, a timeline of meaningful acquisitions and divestures, and the Burton-Taylor view of the opportunities and challenges presented by the transaction.
CRITICAL: This report does NOT carry “enterprise” distribution rights. It may be shared with “up to five users, within the same firm”. Should you require enterprise distribution rights, the right to share the report or data with other firms, or the right to use the report or data in regulatory filings or publicly available marketing materials, please email firstname.lastname@example.org for pricing.
For the “whole story” on the Global Exchange industry, see the comprehensive, five-year, Exchange Global Share & Segment Sizing 2017 (Key Competitors, Global Market Share 2016, Global Segment Sizing 2016, Global Market Trending 2012-16, Global Segment Trending 2012-16 report here.